US headwinds soften MedAdvisor profit


Community pharmacy in the US is facing new competition from digital entrants such as Amazon, while market uncertainty is affecting vaccine uptake, the ASX-listed company says Pharmacy software company MedAdvisor says it continued to face challenges in the fourth quarter, with the group’s gross profit down by more than 28%, it told investors. After selling

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous ‘Huge’ opportunity for pharmacist prescribing
Next PSA names nation’s leading pharmacists